Führer D - Search Results

1

[Molecular pathogenesis of thyroid tumors].

Tiedje V, Zwanziger D, Ting S, Schmid KW, Führer D. Tiedje V, et al. Among authors: fuhrer d. Dtsch Med Wochenschr. 2015 Apr;140(8):578-82. doi: 10.1055/s-0041-101491. Epub 2015 Apr 7. Dtsch Med Wochenschr. 2015. PMID: 25850786 German.

2

[Molecular Pathogenesis of Thyroid Nodules: Relevance for Clinical Care].

Führer D, Musholt T, Schmid KW. Führer D, et al. Laryngorhinootologie. 2017 Sep;96(9):590-596. doi: 10.1055/s-0043-109180. Epub 2017 Sep 7. Laryngorhinootologie. 2017. PMID: 28881369 Review. German.

3

[Medullary thyroid carcinoma].

Tiedje V, Ting S, Dralle H, Schmid KW, Führer D. Tiedje V, et al. Among authors: fuhrer d. Internist (Berl). 2015 Sep;56(9):1019-31. doi: 10.1007/s00108-014-3638-z. Internist (Berl). 2015. PMID: 26338063 German.

4

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.

Broecker-Preuss M, Müller S, Britten M, Worm K, Schmid KW, Mann K, Fuhrer D. Broecker-Preuss M, et al. Among authors: fuhrer d. BMC Cancer. 2015 Mar 26;15:184. doi: 10.1186/s12885-015-1186-0. BMC Cancer. 2015. PMID: 25879531 Free PMC article.

5

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.

Latteyer S, Tiedje V, König K, Ting S, Heukamp LC, Meder L, Schmid KW, Führer D, Moeller LC. Latteyer S, et al. Among authors: fuhrer d. Endocrine. 2016 Dec;54(3):733-741. doi: 10.1007/s12020-016-1080-9. Epub 2016 Oct 1. Endocrine. 2016. PMID: 27696251

6

A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like Phenotype.

Mathew A, Latteyer S, Frank-Raue K, Moeller LC, Zwanziger D, Mengel M, Führer D, Tiedje V. Mathew A, et al. Among authors: fuhrer d. Thyroid. 2021 Feb;31(2):327-329. doi: 10.1089/thy.2019.0472. Epub 2020 Jul 14. Thyroid. 2021. PMID: 32546069

7

[Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology].

Paschke R, Reiners C, Führer D, Schmid KW, Dralle H, Brabant G. Paschke R, et al. Among authors: fuhrer d. Dtsch Med Wochenschr. 2005 Aug 5;130(31-32):1831-6. doi: 10.1055/s-2005-871906. Dtsch Med Wochenschr. 2005. PMID: 16052449 Review. German. No abstract available.

8

Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteins.

Broecker-Preuss M, Baten J, Sheu-Grabellus SY, Görges R, Bockisch A, Schmid KW, Führer D, Mann K. Broecker-Preuss M, et al. Among authors: fuhrer d. Horm Metab Res. 2015 Mar;47(3):200-8. doi: 10.1055/s-0034-1390484. Epub 2014 Nov 5. Horm Metab Res. 2015. PMID: 25372777

9

Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.

Tiedje V, Ting S, Walter RF, Herold T, Worm K, Badziong J, Zwanziger D, Schmid KW, Führer D. Tiedje V, et al. Among authors: fuhrer d. Eur J Endocrinol. 2016 Sep;175(3):173-80. doi: 10.1530/EJE-16-0252. Epub 2016 Jun 9. Eur J Endocrinol. 2016. PMID: 27283290

10

Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism.

Badziong J, Ting S, Synoracki S, Tiedje V, Brix K, Brabant G, Moeller LC, Schmid KW, Fuhrer D, Zwanziger D. Badziong J, et al. Among authors: fuhrer d. Eur J Endocrinol. 2017 Sep;177(3):243-250. doi: 10.1530/EJE-17-0279. Epub 2017 Jun 2. Eur J Endocrinol. 2017. PMID: 28576880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page